APA (7th ed.) Citation

Amano, M., Maeda, K., Tsuchiya, K., Shimada, S., & Mitsuya, H. (2022). Third-Dose BNT162b2 Vaccination Elicits Markedly High-Level SARS-CoV-2–Neutralizing Antibodies in Vaccinees Who Responded Poorly to a Second Dose in Japan. The Journal of infectious diseases, 226(11), 2038-2039. https://doi.org/10.1093/infdis/jiac209

Chicago Style (17th ed.) Citation

Amano, Masayuki, Kenji Maeda, Kiyoto Tsuchiya, Shinya Shimada, and Hiroaki Mitsuya. "Third-Dose BNT162b2 Vaccination Elicits Markedly High-Level SARS-CoV-2–Neutralizing Antibodies in Vaccinees Who Responded Poorly to a Second Dose in Japan." The Journal of Infectious Diseases 226, no. 11 (2022): 2038-2039. https://doi.org/10.1093/infdis/jiac209.

MLA (9th ed.) Citation

Amano, Masayuki, et al. "Third-Dose BNT162b2 Vaccination Elicits Markedly High-Level SARS-CoV-2–Neutralizing Antibodies in Vaccinees Who Responded Poorly to a Second Dose in Japan." The Journal of Infectious Diseases, vol. 226, no. 11, 2022, pp. 2038-2039, https://doi.org/10.1093/infdis/jiac209.